investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Assessment of the benefits and risks of cancer treatments
Sarah Darby
0 Collaborator(s)
Funding source
Medical Research Council (MRC)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Timothy L Lash
Does Stanniocalcin Predict Late Breast Cancer Recurrence, or Is It a Fish Story?
Breast
Radiation Oncology
Zihua Gong
Targeting the DNA repair pathway choice in breast cancer treatment
Breast
Valentin Gomez Farias
Low Cost Automated Ultrasound for Breast Cancer Detection and Diagnosis
Breast
Global Noncommunicable Diseases Intiatives
Local Cooperation Fund (LCF) in Palestinian Adm. Areas - 2
Breast
Anant Madabhushi
Pathology Image Informatics Platform for visualization, analysis and management
Prostate
Breast
Pathology
Ronald G Blasberg
Imaging and Targeting Metastatic-Prone Breast Cancer
Breast
Hallgeir Rui
Prolactin pathways and metastatic progression of ER-positive breast cancer
Breast
Esther M John
Breast Cancer Family Registry Cohort
Breast
Pathology
Joaquin Barnoya
Neoadjuvant Endocrine Therapy in Locally Advanced Hormone Receptor Positive Breast Cancer in a Low-Middle-Income Country (LMIC), Guatemala
Breast